KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation

author
created [InstanceEdit:9680525] Rothfels, Karen, 2020-03-27
dbId 9680524
displayName KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation
journal J. Clin. Oncol.
pages e93-6
pubMedIdentifier 24687822
schemaClass LiteratureReference
title KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation
url http://www.ncbi.nlm.nih.gov/pubmed/24687822
volume 33
year 2015
Cite Us!